Holen Sie sich die Stockscreener-App
6.91
0.58%
-0.04
Handel nachbörslich:
6.94
0.03
+0.43%
Schlusskurs vom Vortag:
$6.95
Offen:
$6.83
24-Stunden-Volumen:
351.67K
Relative Volume:
1.30
Marktkapitalisierung:
$262.84M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
2.3345
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
-0.58%
1M Leistung:
+18.12%
6M Leistung:
-15.32%
1J Leistung:
-64.07%
1-Tages-Spanne:
$6.35
$7.02
1-Wochen-Bereich:
$6.0901
$7.10
52-Wochen-Spanne:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Firmenname
Entrada Therapeutics Inc
Sektor
Branche
Telefon
857-305-1825
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Vergleichen Sie TRDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
6.91 | 264.36M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-01-05 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-03 | Eingeleitet | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten
Why Entrada Therapeutics Inc. stock is favored by pension fundsMarket Growth Review & AI Driven Price Forecasts - newser.com
How risky is Entrada Therapeutics Inc. stock nowGDP Growth & Reliable Momentum Entry Alerts - newser.com
Can Entrada Therapeutics Inc. stock resist market sell offsMarket Growth Summary & Precise Swing Trade Alerts - newser.com
Analyzing Entrada Therapeutics Inc. with multi timeframe charts2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Entrada Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Published on: 2025-11-06 22:32:58 - newser.com
Entrada Therapeutics price target lowered to $13 from $17 at Roth Capital - TipRanks
Promising Outlook for Entrada Therapeutics: Strategic Advancements in DMD and DM1 with Novel EEV Platform - TipRanks
Entrada Therapeutics Faces Losses But Keeps Wall Street’s Support - Finimize
Promising Advancements and Strategic Positioning Drive Buy Rating for Entrada Therapeutics Inc. - TipRanks
Entrada Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Entrada Therapeutics may issue up to $400 million in securitiesSEC filing - MarketScreener
Entrada Therapeutics earnings missed by $0.07, revenue fell short of estimates - Investing.com Canada
Entrada Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Entrada Therapeutics Q3 net loss widens to $44.1 mln - MarketScreener
Entrada Therapeutics Reports Third Quarter 2025 Financial Results - The Manila Times
Entrada Therapeutics (NASDAQ: TRDA) extends runway into 2027, ends quarter with $326.8M - Stock Titan
Is Entrada Therapeutics Inc. forming a bottoming baseInflation Watch & Real-Time Buy Signal Alerts - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.Portfolio Gains Report & Stock Timing and Entry Methods - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peers2025 Dividend Review & Daily Chart Pattern Signal Reports - newser.com
Will Entrada Therapeutics Inc. stock gain from strong economyWeekly Trend Report & Risk Adjusted Swing Trade Ideas - newser.com
Applying big data sentiment scoring on Entrada Therapeutics Inc.Trade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-05 12:10:19 - newser.com
Real time pattern detection on Entrada Therapeutics Inc. stockQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Published on: 2025-11-04 23:42:29 - newser.com
Visualizing Entrada Therapeutics Inc. stock with heatmapsWeekly Profit Recap & Accurate Intraday Trade Tips - newser.com
Understanding Entrada Therapeutics Inc.’s price movementJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Entrada Therapeutics, Inc. (TRDA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Entrada Therapeutics, Inc. (TRDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Published on: 2025-11-03 06:13:01 - newser.com
Entrada Therapeutics, Inc. (TRDA) stock forecast and price target - Yahoo! Finance UK
Applying sector rotation models to Entrada Therapeutics Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Entrada Therapeutics Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):